scispace - formally typeset
C

Chao Zhao

Researcher at University of Cambridge

Publications -  92
Citations -  9650

Chao Zhao is an academic researcher from University of Cambridge. The author has contributed to research in topics: Remyelination & Oligodendrocyte. The author has an hindex of 46, co-authored 90 publications receiving 8332 citations. Previous affiliations of Chao Zhao include Wellcome Trust & University of Bristol.

Papers
More filters
Journal ArticleDOI

Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.

TL;DR: A significant impairment of remyelination is found, attributable to an arrest of the differentiation and not the recruitment of oligodendrocyte precursor cells, which identifies myelin as an inhibitor of remYelination as well as its well documented inhibition of axon regeneration.
Journal ArticleDOI

Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS

TL;DR: It is shown that dysregulation of Wnt-beta-catenin signaling in OLPs results in profound delay of both developmental myelination and remyelination, based on findings from APC(Min) mice, which lack one functional copy of the endogenous Wnt pathway inhibitor APC.
Journal ArticleDOI

The Age-Related Decrease in CNS Remyelination Efficiency Is Attributable to an Impairment of Both Oligodendrocyte Progenitor Recruitment and Differentiation

TL;DR: The results indicate that the age-associated decrease inRemyelination efficiency occurs because of an impairment of OP recruitment and the subsequent differentiation of the OPs into remyelinating oligodendrocytes, and that strategies aimed at ameliorating the age -associated decline in remyELination efficiency will therefore need to promote both components of the regenerative process.
Journal ArticleDOI

Retinoid X receptor gamma signaling accelerates CNS remyelination

TL;DR: The results indicate that RXR-γ is a positive regulator of endogenous oligodendrocyte precursor cell differentiation and remyelination and might be a pharmacological target for regenerative therapy in the CNS.